Skip to content

To compare between ease of intubation by fiberoptic through I-gel vs blockbuster LMA

A comparison of i-gel plus and blockbuster LMA as a conduit to fiberoptic guided intubation - Nil

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102640
Enrollment
80
Registered
2026-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Patients who will be intubated through I-gel plus: Patient will be intubated using fiberoptic through I-gel plus Control Intervention1: Patient will be intubated through blockbuster LMA

Sponsors

Pt BD Sharma PGIMS rohtak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients aged between 18-60 years of either sex of ASA grade I and II scheduled for elective surgery requiring general anesthesia and endotracheal intubation will be included.

Exclusion criteria

Exclusion criteria: Patients having respiratory or oral pathology, mouth opening Less than 2.0 cms, Body mass index greater than 30, pregnancy, full stomach, suspected difficult airway will be excluded.

Design outcomes

Primary

MeasureTime frame
Primary objective of the study is to evaluate the time taken to place the endotracheal tube using i-gel Plus and Blockbuster LMA.Timepoint: total time taken to place the endotracheal tube.

Secondary

MeasureTime frame
Oropharyngeal leak pressure of supraglottic deviceTimepoint: After insertion of supraglottic device & before insertion of fiberoptic device;Time taken to place and ease of placement of the supraglottic deviceTimepoint: Time to noted in seconds after appropriate muscle relaxation is noted;The number of insertion attempts and ease of intubationTimepoint:

Countries

India

Contacts

Public ContactYaduvendra

Pt. B.D Sharma PGIMS Rohtak

Anshulpooja03@gmail.com9034552949

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026